Member Info for Sagetrade

Don’t worry, I’m off. No agenda whatsoever, read my posting history all the way back. Don’t come on here to take abuse just because I have some concerns in the short term. Don’t understand why people can’t be reasonable and respond with counter arguments rather than abuse....

This board used to be a home for informed debate, discussing pros and cons of the stock, is now a home for confirmation bias where the loudest voices shout down anyone they perceive to be spouting a negative opinion.

Will join (some much better and more informed posters than me) the others on the sidelines.

GLA

Thanks for your kind words and sorry for offering my
opinion on, yes - an opinion board.

What a piece of work you are...

Does it? Suppose it does if you take the CEO’s rhetoric as gospel.

Devil in the detail:
- BAMS delay due to lack of samples within condor - no manufacturing partners in place yet
- LFT miles away (early 2021 for sales) IMO. Tech transfer still not complete, separate study needed for direct to consumer use (ie Moonshot), doesn’t explicitly say we are in CONDOR for LFT whereas it does for BAMS. Also an admission of how difficult it is to set up mass production vs prototype build.

Risk, reward scales moving in the wrong direction IMO...cue the abuse !

Any "look forward to updating in due course" or "by the end of the Autumn" will be met with disdain by many given previous soundbites.

He needs to give clarity and certainty (as far as feasibly possible) on timelines, even if that is not imminently or perceived good news. Whether an internal issue or something out of control, the lack of decent comms and wishy-washy timelines has been very frustrating.

Clearly may be out of AS's hands, in which case say as much and be honest about timelines relying on 3rd parties delivering.

Still invested Muir?

Looks likely that they are!!!

Frankly, I wouldn’t go near a company that has such a flash Harry as CEO... bloke must spend more time on twitter than he does at his desk.

Blatant ramping pre RNS over the last few day’s and this morning, just comes across as totally unprofessional -

IMO

sell? That is worrying.......insider info?

Think you better check your pricing instrument pal.......

I don't disagree. £10 per share is realistic in the medium term and I still believe they will get the test out, just enormously frustrating given where we could be. I actually thought November would be likely for sales a couple of weeks back, but now think that could be pushed into the new year but who knows. I tend to agree that once tech transfer is complete, validation may come soon after...

As you say, the whole point of existence of boards like this should be for informed debate and analysis as to form part of an investors decision making. Not, as is often the case, post after post of confirmation bias......

Another one eyed idiot....at least make an intelligent point.

Where did I say I or anyone else can run the company better or that we shouldn't be part of Moonshot? I simply said some investors have legitimately held concerns over the delays and lack of news. If you can't accept that as a valid opinion then I'm afraid your beyond help.

Waste of time arguing with a moron, so I won't bother. Have a great day.

Hilarious - as I say look through my posting history. There is obviously many good posters on here, but it's simply disingenuous to call out the likes of AlwaysWinning for his blatant deramping attempts and not point out that there is at least as many one eyed posters in the other direction who refuse to accept any element of criticism or questioning of the company and it's leadership.

This fascination with the idea that the silence is due to Moonshot is also comically unfounded. AS would have to RNS any price sensitive information, NDA / Moonshot or not. Clearly tech transfer has not been completed so how do "know the test is complete"?

Also, "ramping another test"?! I must be mistaken but I thought this was a board for discussion and insight rather than just a repository of one-sided Avacta love in posts only?

Take a moment to actually go through my posting history, rather than having a paddy because I won't jump on the ludicrous, tunnel visioned thinking of some on here.

Nothing wrong with having a realistic view of where we are. Deadlines have been missed and it would appear we are still in the process of tech transfer for the LFT. BAMS still hasn't been validated through CONDOR and I think it's unlikely any major news will drop before interims on Monday.

I think it's okay and indeed perfectly reasonable to feel somewhat frustrated about where we are given the CEO's suggestions earlier in the year...

No doubt the opportunity is still there and the long term outlook for Avacta is still very strong, but some of the posts on here insinuating validation, S&S figures and £10+ per share are around the corner are frankly ill-informed tripe.

I believe validation will come, as will sales, but not in the next few days or weeks.

Happy, of course, to be proven wrong.

Your ramping is comical......

Sky news report tonight on a 15 min saliva lft...test at home etc.

Surescreen diagnostics.

AS needs to pull his finger out and quick.

It’s a shambles and AS has missed the boat worldwide by putting all his eggs in the basket of this comical government. Nothing been submitted to FDA etc, clear we are waiting on government led third parties and the opportunity cost is becoming absolutely massive. Such a shame.

The fact that nothings changed is probably what the issue is here for many....!

Forget the LFT for now, the fact there has been no BAMS update is frankly staggering.

Let's hope we are under some sort of NDA, although personally can't see it. Either way, we should know in the next few weeks whether this is going to fly or not.

Fear for Sir Al's wellbeing in the Q&A if there is no meaningful testing RNS before next Monday!

“Even you can wait for the update on the 28th.” Your words.

They can’t release any price sensitive info in the presentation.....actually needs to be some news beforehand or it’s going to be an incredibly awkward q & a

The lack of info over the past few weeks (on BAMS particularly) has been frankly staggering.